Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 300
- 主要终点
- Incidence of surgical complications
研究概览
简要总结
This trial is a multicenter prospective cohort study to explore timing of colorectal cancer surgery after COVID-19 infection so that can assist clinicians and patients. Currently, there is less evidence on perioperative outcomes after COVID-19 vaccination and the omicron variant. Therefore, it is necessary to update previously published consensus which recommends that patients should avoid elective surgery within 7 weeks of COVID-19 infection remain, unless the benefits of doing so exceed the risk of waiting. Aiming at the above problems, we plan to carry out a multicenter prospective cohort study to develop perioperative management according patients' different conditions.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •undergoing colorectal cancer surgery
- •infected with COVID-19 but nucleic acid test result is negative
- •the patients compliance is good
- •signed the consents voluntarily
排除标准
- •undergoing emergency surgery(intestinal obstruction, intestinal perforation, intestinal hemorrhage, et al.)
- •The patients' situations which judged by situations is not suitable to participate in the clinical trial
结局指标
主要结局
Incidence of surgical complications
时间窗: 30 days after surgery
Complications including: intraperitoneal hemorrhage, anastomotic leak, anastomotic bleeding, abdominal infection, pulmonary infection, chylous fistula, intestinal obstruction, et al.
次要结局
未报告次要终点